D Management Said Key to Progress

DENVER—Improved management of technology in general, and of R&D in particular, is the key to U.S. progress in the competitive '80s, according to participants in two sessions at the American Chemical Society meeting here last month. And meeting vigorous overseas competition demands effective financial cooperation between government and industry. Of the many actions required to respond to the challenge from abroad, asserted William Norris, chairman emeritus of Control Data Corporation, "non

Written byPeter Gwynne
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Of the many actions required to respond to the challenge from abroad, asserted William Norris, chairman emeritus of Control Data Corporation, "none is more important in an era of fierce competition than better managing our technology, especially to increase the efficiency of creating and applying it'

A major ingredient of such management, said Norris at a session on competitiveness, is "a vast in-crease in large-scale technological cooperation among corporations, universities and government." His prescription for achieving that: "The immediate formation of large-scale ventures in many industries," modeled after the Microelectronics and Computer Company (MCC), established with Norris' help in 1982.

Because overseas competition and domestic corporate raids have reduced the money available to U.S. industry for R&D, however, "federal and state funding is required to establish cooperative R&D consortia," Norris said.

Presidential science adviser William Graham put the spotlight on industry's role in moving basic science into market applications. "We ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies